Skip to main content
SpringerLink
Log in

CED im höheren Lebensalter

  • Chapter
  • First Online:
Chronisch-entzündliche Darmerkrankungen

  • 3579 Accesses

Zusammenfassung

Klinische Daten zu Verlauf und Prognose der CED bei Älteren liegen nur wenige vor, wenngleich bis zu 35 % des Gesamtkollektivs von CED-Patienten älter als 60 Jahre sind. Der Zeitraum zwischen Beginn der Symptomatik und Diagnosestellung ist üblicherweise länger, Fehldiagnosen sind häufig in Anbetracht der vielen Differenzialdiagnosen beim alten Menschen. In den meisten klinischen Studien werden ältere CED Patienten entweder unzureichend oder überhaupt nicht abgebildet, dabei sind Diagnostik und Therapie in dieser Lebensphase durch eine Vielzahl von Faktoren wie veränderte Pharmakokinetik, eingeschränkte Nierenfunktion, häufige Komorbiditäten und die allfällige Polypharmazie erschwert. Im nachfolgenden Kapitel sollen die für den klinischen Alltag relevanten Besonderheiten in der Diagnostik und Therapie älterer Patienten mit CED dargestellt werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Ananthakrishnan AN, Donaldson T, Lasch K (2017) Management of inflammatory bowel disease in the elderly patient: challenges and opportunities. Inflamm Bowel Dis 23(6):882–893

    Article  Google Scholar 

  • Arnott I, Rogler G, Halfvarson J (2017) The management of inflammatory bowel disease in elderly: current evidence and future perspectives. Inflamm Intest Dis 2:189–199

    Article  Google Scholar 

  • Beaugerie L (2013) Lymphoma: The Bête Noire of the long-term use of thiopurines in adult and elderly patients with inflammatory bowel disease. Gastroenterology 145:927–930

    Article  CAS  Google Scholar 

  • Biagi E, Candela M, Fairweather-Tait S et al (2012) Ageing of the human metaorganism: the microbial counterpart. Age 34:247–267

    Article  Google Scholar 

  • Bollegala N, Jackson TD, Nguyen GC (2016) Increased postoperative mortality and complications among elderly patients with inflammatory bowel diseases: an analysis of the National Surgical Quality Improvement Program Cohort. Clin Gastroenterol Hepatol 14:1274–1281

    Article  Google Scholar 

  • Brassard P, Bitton A, Suissa A et al (2014) Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel disease. Am J Gastroenterol 109:1795–1802

    Article  CAS  Google Scholar 

  • Burr NE, Lord R, Hull MA, Subramanian V (2019) Decreasing risk of first and subsequent surgeries in patients with Crohn’s disease in England from 1994 through 2013. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2018.12.022

    Article  PubMed  Google Scholar 

  • Calafat M, Manosa M, Canete F et al (2018) The initiation of thiopurines in elderly patients with inflammatory bowel disease is associated with an increased risk of adverse effects: a case-control study of the ENEIDA registry. J Crohns Colitis 12(1):023–025

    Google Scholar 

  • Chaparro M, Ordas I, Cabre E et al (2013) Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients. Inflamm Bowel Dis 19:1404–1410

    Article  Google Scholar 

  • Charpentier C, Salleron J, Savoye G et al (2014) Natural history of elderly onset inflammatory bowel disease: a population-based cohort study. Gut 63:423–432

    Article  Google Scholar 

  • Cottone M, Kohn A, Daperno M et al (2011) Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol 9:30–35

    Article  CAS  Google Scholar 

  • Curtis JR, Schulze-Koops H, Takiya L et al (2017) Efficacy and safety of tofacitinib in older and younger patients with rheumatoid arthritis. Clin Exp Rheumatol 35:390–400

    PubMed  Google Scholar 

  • Everhov AH, Halfvarson J, Myrelid P et al (2018) Incidence and treatment of patients diagnosed with inflammatory bowel disease at 60 years or older in Sweden. Gastroenterology 154:518–528

    Article  Google Scholar 

  • Fries W, Viola A, Manetti N et al (2017) Disease patterns in late onset ulcerative colitis: results from the IG-IBD „AGED study“. Dig Liver Dis 49:17–23

    Article  Google Scholar 

  • Jeuring SF, van den Heuvel TR, Zeegers MP et al (2016) Epidemiology and longterm outcome of inflammatory bowel disease diagnosed at elderly age – an increasing distinct entity? Inflamm Bowel Dis 22:1425–1434

    Article  Google Scholar 

  • Kaplan GG, Ng SC (2017) Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 152:313–321

    Article  Google Scholar 

  • Katz S, Pardi DS (2011) Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol 106:1889–1897

    Article  Google Scholar 

  • Kedia S, Limdi JK, Ahuja V (2018) Management of inflammatory bowel disease in older persons: evolving paradigms. Intest Res 16(2):194–208

    Article  Google Scholar 

  • Khan N, Abbas AM, Lichtenstein GR et al (2013) Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study. Gastroenterology 145:1007–1015

    Article  CAS  Google Scholar 

  • Kirchgesner J, Lemaitre M, Carrat F et al (2018) Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases. Gastroenterology. 155:337–346

    Google Scholar 

  • Lakatos PL, David G, Pandur T et al (2011) IBD in the elderly population: results from a population-based study in Western Hungary, 1977–2008. J Crohns Colitis 5:5–13

    Article  Google Scholar 

  • Lichtenstein GR, Feagan BG, Cohen RD et al (2018) Infliximab for Crohn’s disease: more than 13 years of real-world experience. Inflamm Bowel Dis 24:490–501

    Article  Google Scholar 

  • Lobaton T, Ferrante M, Rutgeerts P et al (2015) Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther 42:441–451

    Article  CAS  Google Scholar 

  • Lynn AM, Loftus EV (2018) Illuminating the Black Box: The Real Risk of Serious Infection With Inflammatory Bowel Disease Therapies. Gastroenterology 155:262–265

    Google Scholar 

  • Rahier JF, Magro F, Abreu C et al (2014) Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 8:443–468

    Article  CAS  Google Scholar 

  • Ruel J, Ruane D, Mehandru S et al (2014) IBD across the age spectrum – is it the same disease? Nat Rev Gastroenterol Hepatol 11:88–98

    Article  Google Scholar 

  • Sato S et al (2015) Mucosal immunosenescence in the gastrointestinal tract. Gerontology 61:336–342

    Article  CAS  Google Scholar 

  • Song EM, Lee HS, Park SH et al (2018) Clinical characteristics and long-term prognosis of elderly-onset ulcerative colitis. J Gastroenterol Hepatol 33:172–179

    Article  Google Scholar 

  • Sturm A, Maaser Ch, Mendall M et al (2017) European Crohn’s and colitis organisation topical review on IBD in the elderly. J Crohns Colitis 11:263–273

    Article  Google Scholar 

  • Subramaniam K, D’Rozario J, Pavli P (2013) Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review. J Gastroenterol Hepatol 28:24–30

    Article  CAS  Google Scholar 

  • Tan VP, Chung A, Yan BP, Gibson PR (2013) Venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol 28:1095–1113

    Article  Google Scholar 

  • Tilg H, Moschen AR, Kaser A, Pines A, Dotan I (2008) Gut, inflammation and osteoporosis: basic and clinical concepts. Gut 57:684–694

    Article  CAS  Google Scholar 

  • Tran AH, Man Ngor EW, Wu BU (2014) Surveillance colonoscopy in elderly patients: a retrospective cohort study. JAMA 174:1675–1682

    Google Scholar 

  • Yajnik V, Khan N, Dubinsky M et al (2017) Efficacy and safety of vedolizumab in ulcerative colitis and Crohn’s disease patients stratified by age. Adv Ther 34:542–559

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MVZ Agaplesion Frankfurt, Frankfurt, Deutschland

    Franz Hartmann

Authors
  1. Franz Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Franz Hartmann .

Editor information

Editors and Affiliations

  1. Medizinische Klinik I, St. Marien- und St. Annastiftskrankenhaus, Ludwigshafen, Germany

    Jörg C. Hoffmann

  2. Klinik für Innere Medizin, Medius-Klinik Ostfildern-Ruit, Ostfildern, Germany

    Bodo Klump

  3. Allg.-, Viszeral- & Unfallchirurgie, Krankenhaus Porz am Rhein, Köln, Germany

    Anton Kroesen

  4. Medizinische Klinik I, Charité – Universitätsmedizin Berlin, Berlin, Germany

    Britta Siegmund

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hartmann, F. (2020). CED im höheren Lebensalter. In: Hoffmann, J.C., Klump, B., Kroesen, A., Siegmund, B. (eds) Chronisch-entzündliche Darmerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59104-8_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-59104-8_31

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-59103-1

  • Online ISBN: 978-3-662-59104-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation